24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Both the Oxford PharmaGenesis US (Brian Falcone and Jake Willet) and UK (Eric Southam and Richard White) offices were represented at The International Publication Planning Meeting (TIPPA) East, in Boston on 24–25 June 2019.
In aid of three Oxfordshire-based charities, three employees of HealthScience communications consultancy Oxford PharmaGenesis scaled the three highest peaks in England, Scotland and Wales within 24 hours comprising the Trifecta 3Peaks Challenge.
Who is publishing their clinical trial results? Do biopharmaceutical industry sponsors carry an unfair burden of the blame for the under-reporting of clinical trial results?
After more than 2 years of hard work, Aston & Cote Summer Fete (held on 22 June) was the perfect event for Aston & Cote Community Trust to celebrate the opening of a new playground for the young children of the village.
Leading medical journals restrict access to industry-funded research, shows a study conducted by researchers at Oxford PharmaGenesis, published in BMJ Open today. This is likely to impede further research and delay patient benefit.
It’s official – Oxford PharmaGenesis is a great place to work on both sides of the Atlantic! At the end of 2018, we won the award in our US office, and today we are proud to announce that we have also received the award in the UK, with 89% of employees rating the company a…
